Sihuan Pharmaceutical Holdings Group Ltd. - ROE

The ROE as of July 2026 (TTM) for Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) is 3.51%

According to Sihuan Pharmaceutical Holdings Group Ltd.’s latest financial reports and current stock price. The company's current ROE is 3.51%. This represents a change of -1188.92% compared to the average of -0.32% of the last 4 quarters.

Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) Historical ROE (quarterly & annually)

How has 0460.HK ROE performed in the past?

The mean historical ROE of Sihuan Pharmaceutical Holdings Group Ltd. over the last ten years is -2.03%. The current 3.51% ROE has changed -273.05% with respect to the historical average. Over the past ten years (40 quarters), 0460.HK's ROE was at its highest in in the December 2006 quarter at 30.25%. The ROE was at its lowest in in the December 2022 quarter at -42.04%.

Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Sihuan Pharmaceutical Holdings Group Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) Average ROE

How has 0460.HK ROE performed in the past?

The current ROE of Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) ROE vs. Peers

How is 0460.HK’s ROE compared to its peers?

Sihuan Pharmaceutical Holdings Group Ltd.’s ROE is less than Consun Pharmaceutical Group Limited (24.26%), greater than China Traditional Chinese Medicine Holdings Co. Limited (-1.66%), greater than Ab&B Bio-Tech Co. Ltd. JS (-253.66%), greater than CanSino Biologics Inc. (-0.02%), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (-38.11%), less than Shandong Xinhua Pharmaceutical Company Limited (5.02%), less than Luye Pharma Group Ltd. (4.02%), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (3.12%), less than SSY Group Limited (6.46%), less than Angelalign Technology Inc. (5.84%),

Build a custom stock screener for Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sihuan Pharmaceutical Holdings Group Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sihuan Pharmaceutical Holdings Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.